• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

pillow

anonymous

Guest
spent the last few days at a mtg in Boston. What a waste of time. was spoken too like we are kids. Give us a break. BS and more BS. Oh yes the ass kissing continues, embarrassing.